Four Members of Congress Receive the 2001 Paul E. Tsongas Award

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 10 No 6
Volume 10
Issue 6

WASHINGTON-Four members of Congress received the 2001 Paul E. Tsongas Memorial Award for their contributions to forwarding cancer research and awareness of the disease. This year’s honorees were Sen. Edward M. Kennedy (D-Mass), Sen. Mike DeWine (R-Ohio), Rep. C. W. Bill Young (R-Fla), and Rep. Lois Capps (D-Calif).

WASHINGTON—Four members of Congress received the 2001 Paul E. Tsongas Memorial Award for their contributions to forwarding cancer research and awareness of the disease. This year’s honorees were Sen. Edward M. Kennedy (D-Mass), Sen. Mike DeWine (R-Ohio), Rep. C. W. Bill Young (R-Fla), and Rep. Lois Capps (D-Calif).

The annual Tsongas award recognizes "outstanding legislative leadership and commitment in support of health care issues that result in improving the quality of life for all Americans."

It is presented by the Lymphoma Research Foundation of America and named for the late Sen. Paul Tsongas (D-Mass), who served as the group’s honorary chair from its inception until his death in 1997 from complications associated with his treatment for lymphoma.

The awards were presented at a Capitol Hill reception. Only Sen. Kennedy was able to attend the ceremony (see photograph). In his acceptance remarks, Sen. Kennedy noted that his son, Rep. Patrick J. Kennedy (D-RI), who was in the audience, received the Tsongas award last year.

"You see, he’s learning from me," Patrick Kennedy quipped to laughter and applause. "He’s coming along nicely."

In a more serious moment, Sen. Kennedy noted the successful work of the Human Genome Project and its potential. "When we look at the possibilities today, I firmly believe that this period of our time will be known as the time of the life sciences," he said. "It is the life sciences that are going to mark the way toward finding important paths for dealing with these challenges in lymphoma."

The senator, whose son Edward suffered from osteosarcoma as a child, also praised the efforts of advocacy groups like the Lymphoma Research Foundation. "I am all for what the government, the NIH, can do, and there is nothing that can replace that," Senator Kennedy said. "But the work this foundation does—in terms of the research it funds and in getting information out—is something that is enormously important, and I hope you know that."

Recent Videos
Point-of-care manufacturing, scalable manufacturing, and bringing the cost down [can help].
Louis Potters, MD, FASTRO, FABS, FACR, describes how evidence-based radiation protocols may integrate with novel artificial intelligence software.
The use of enhanced imaging and adaptive radiotherapy has lessened the burden on patients with cancer receiving radiotherapy as treatment.
7 experts are featured in this series.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Related Content